30 Minutes to Relief? Real-World Data Say Yes - Summary - MDSpire
Advertisement
30 Minutes to Relief? Real-World Data Say Yes
Real-world patient-reported outcomes show high responder rates, favorable tolerability, and consistent satisfaction with hyoscine butylbromide plus for menstrual pain self-treatment.
To assess the effectiveness, utilization patterns, and safety of Hyoscine butylbromide (HBB) Plus tablets for self-treatment of dysmenorrhea in adult women.
Key Findings:
Median time to meaningful pain relief was 38 minutes.
91% of patients achieved a clinically meaningful response within 4 hours.
Pain intensity decreased significantly at all postdose assessments, with a mean reduction of 2 points at 30 minutes and 4 points at 4 hours.
The proportion of patients reporting at least one dysmenorrhea symptom decreased from 96% at baseline to 70% at 4 hours.
Interpretation:
The study demonstrated that HBB Plus is effective and well-tolerated for reducing menstrual pain, with high patient satisfaction (over 90% reported satisfaction).
Limitations:
Observational study design without a comparator group.
Small primary analysis cohort of only 98 patients.
Study population limited to Germany and reliant on self-reported data, which may introduce selection bias.
Conclusion:
HBB Plus tablets provide rapid and significant relief from menstrual pain, with a majority of patients reporting satisfaction with treatment effectiveness.
